Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Ingenious Brazilian billboards use fake sweat to attract and kill Zika-carrying mosquitos

Add as a preferred source on Google

As the Zika virus continues to plague South America, two Brazilian companies have designed a small billboard sign that traps and kills the carrier of the disease –the Aedes Aegypti mosquito– according to International Business Times.

Advertising agencies NBS and Posterscope, designed and built the signs, which slowly release lactic acid and carbon dioxide from canisters stored inside, mimicking human sweat and breath respectively. The designers say this cocktail will attract mosquitos from as far as 2.5 miles. Fluorescent tube lights further direct the mosquitos inside, and coax them into a one-way tube. It’s sort of like those d-Con Roach Motels from the 1970s (Roaches check in, but they don’t check out!), but designed specifically for mosquitos. Eventually, the mosquitos die of dehydration and pile up in a tray on the bottom of the sign.

Recommended Videos

The companies have set up a website with an explanation how The Mosquito Killer Billboard works. There’s also an exploded component view, which makes it easy for other groups to build their own DIY versions.

Since the first reported outbreak in Brazil in May 2015, the World Health Organization has gone on to declare Zika virus as a global health emergency. Confirmed cases of Zika virus have spread throughout Central and South America and in the southern United States. The disease is difficult to diagnose because four out of five infected people show no symptoms, but can still be carriers. Pregnant women infected with the Zika virus can pass it on to their babies, which can result in smaller than normal heads and brain development issues. Because the Aedes Aegypti (also known as the Yellow Fever mosquito) is the carrier, any effective technology for eradicating them can only help.

Bruce Brown
Bruce Brown Contributing Editor   As a Contributing Editor to the Auto teams at Digital Trends and TheManual.com, Bruce…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more